Maurie Markman, MD

Among patients with high-risk early-stage epithelial ovarian cancer, 72% had at least one symptom, the most common of which was abdominal or pelvic pain, according to a retrospective study in Obstetrics & Gynecology.

In the final installment of a four-video series timed to Cervical Cancer Awareness Month, Maurie Markman, MD, spoke with Healio about which adults may derive the most benefit from catch-up HPV vaccination.

In the third installment of a four-video series timed to Cervical Cancer Awareness Month, Maurie Markman, MD, spoke with Healio about how clinicians can help overcome HPV vaccine hesitancy.

In the second installment of a four-video series timed to Cervical Cancer Awareness Month, Maurie Markman, MD, spoke with Healio about the impact of HPV vaccination on the global burden of cervical cancer.

In the first installment of a four-video series timed to Cervical Cancer Awareness Month, Maurie Markman, MD, spoke with Healio about the importance of HPV vaccination.

There is considerable excitement in the gynecologic cancer research community with the pending results of several randomized phase-3 trials that examine the utility of antiangiogenic therapy in the management of ovarian cancer and with the early results of a number of targeted antineoplastic agents, including drugs that are known to inhibit poly (ADP-ribose) polymerase — or PARP.

It is difficult to overstate the importance of data regarding the striking effectiveness of two different human papillomavirus vaccination strategies as a rational approach to prevent the development of cervical cancer. Available information about the vaccines reveals that, assuming a young woman has not previously been exposed to the specific HPV viruses included in either the bivalent or quadrivalent vaccine preparations and that she completes the planned vaccination schedule, the vaccination strategy is nearly 100% effective in preventing persistent infection. This is a recognized, essentially absolute, requirement for the subsequent development of this malignancy.

The importance of effective communication between oncologists and their patients cannot be overstated.